As of 2026-04-05, the Relative Valuation of Kingworld Medicines Group Ltd (1110.HK) is 0.64 HKD. This relative valuation is based on P/E multiples. With the latest stock price at 0.49 HKD, the upside of Kingworld Medicines Group Ltd based on Relative Valuation is 32.6%.
The range of the Relative Valuation is 0.11 - 1.24 HKD.
| Range | Selected | |
| Trailing P/E multiples | 11.3x - 18.0x | 12.9x |
| Forward P/E multiples | 10.0x - 12.9x | 12.0x |
| Fair Price | 0.11 - 1.24 | 0.64 |
| Upside | -76.8% - 156.3% | 32.6% |
| Date | P/E |
| 2026-04-02 | 48.83 |
| 2026-04-01 | 48.33 |
| 2026-03-31 | 50.34 |
| 2026-03-30 | 50.34 |
| 2026-03-27 | 50.34 |
| 2026-03-26 | 50.34 |
| 2026-03-25 | 51.35 |
| 2026-03-24 | 50.34 |
| 2026-03-23 | 50.34 |
| 2026-03-20 | 47.83 |
| 2026-03-19 | 49.34 |
| 2026-03-18 | 49.34 |
| 2026-03-17 | 49.34 |
| 2026-03-16 | 49.84 |
| 2026-03-13 | 51.35 |
| 2026-03-12 | 50.34 |
| 2026-03-11 | 50.34 |
| 2026-03-10 | 50.34 |
| 2026-03-09 | 50.34 |
| 2026-03-06 | 50.34 |
| 2026-03-05 | 49.84 |
| 2026-03-04 | 50.34 |
| 2026-03-03 | 51.35 |
| 2026-03-02 | 51.35 |
| 2026-02-27 | 52.36 |
| 2026-02-26 | 52.36 |
| 2026-02-25 | 52.36 |
| 2026-02-24 | 53.37 |
| 2026-02-23 | 53.37 |
| 2026-02-20 | 55.38 |
| 2026-02-16 | 55.38 |
| 2026-02-13 | 55.38 |
| 2026-02-12 | 56.39 |
| 2026-02-11 | 55.38 |
| 2026-02-10 | 55.38 |
| 2026-02-09 | 55.38 |
| 2026-02-06 | 55.38 |
| 2026-02-05 | 52.36 |
| 2026-02-04 | 54.37 |
| 2026-02-03 | 54.37 |
| 2026-02-02 | 54.37 |
| 2026-01-30 | 53.37 |
| 2026-01-29 | 56.39 |
| 2026-01-28 | 58.40 |
| 2026-01-27 | 59.41 |
| 2026-01-26 | 60.41 |
| 2026-01-23 | 54.37 |
| 2026-01-22 | 52.36 |
| 2026-01-21 | 52.36 |
| 2026-01-20 | 51.35 |